Gold Prices Surge to Highest Level since Early November 2020 at $2,750: A Detailed Analysis

Gold Prices Soar to Highest Level Since November 1: A Three-Day Uptrend Gold prices continued their upward trend on Wednesday, building on the previous two days’ strong gains. The commodity attracted follow-through buying, pushing the price to its highest level since November 1, around the $2,750 area. This impressive uptrend was observed primarily during the…

Read More

Regeneron Investors: Levi & Korsinsky Warns of Approaching Class Action Lawsuit Deadline – March 10, 2025

Class Action Lawsuit Filed Against Regeneron Pharmaceuticals: What Does It Mean for Investors and the World? On February 28, 2025, Levi & Korsinsky, LLP announced the filing of a class action securities lawsuit against Regeneron Pharmaceuticals, Inc. (Regeneron or the Company) (NASDAQ: REGN) on behalf of investors who purchased Regeneron securities between November 2, 2023,…

Read More

Important Deadline Reminder for FMC Corporation Shareholders: Levi & Korsinsky Encourages Investors to Act Before April 14, 2025 in Pending Class Action Lawsuit

Class Action Lawsuit Against FMC Corporation: What Does It Mean for Investors and the World? On February 28, 2025, Levi & Korsinsky, LLP announced the filing of a class action securities lawsuit against FMC Corporation (“FMC” or the “Company”) (NYSE: FMC). The lawsuit, which was filed in the United States District Court for the Eastern…

Read More

Class Action Lawsuit Filed Against Venture Global Inc.: A Recovery Opportunity for Investors – Contact Levi & Korsinsky for Details

Class Action Lawsuit Filed Against Venture Global, Inc.: What Does It Mean for Investors and the World? New York, NY – In a significant development for investors in Venture Global, Inc. (VG), a class action securities lawsuit has been filed against the company. The lawsuit, which was initiated by Levi & Korsinsky, LLP, alleges securities…

Read More

Shareholders Suffering Losses from Revance Therapeutics (INCV) Encouraged to Contact Levi & Korsinsky for Information on Class Action Lawsuit

Class Action Lawsuit Against Revance Therapeutics: What Investors Need to Know On February 28, 2025, Levi & Korsinsky, LLP announced that it had filed a class action lawsuit against Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ: RVNC) on behalf of investors who purchased or otherwise acquired Revance securities between February 29, 2024, and December…

Read More

Important Deadline Reminder for Essa Pharma Inc. Shareholders: Lead Plaintiff Applications Due March 25, 2025 in Class Action Lawsuit against EPix

Class Action Lawsuit Filed Against ESSA Pharma Inc.: What Does It Mean for Investors and the World? On February 28, 2025, Levi & Korsinsky, LLP announced the filing of a class action securities lawsuit against ESSA Pharma Inc. (ESSA Pharma) (NASDAQ: EPIX) on behalf of investors who purchased or otherwise acquired the Company’s securities between…

Read More